600085 同仁堂
已收盘 10-20 15:00:00
资讯
新帖
简况
股市必读：同仁堂新发布《北京大成律师事务所关于北京同仁堂股份有限公司2026年第二次临时股东会的法律意见书》
证券之星 · 10-19 01:28
股市必读：同仁堂新发布《北京大成律师事务所关于北京同仁堂股份有限公司2026年第二次临时股东会的法律意见书》
同仁堂（600085）披露控股股东关于解决和避免同业竞争承诺函议案获通过，10月16日股价下跌1.62%
证券之星 · 10-16
同仁堂（600085）披露控股股东关于解决和避免同业竞争承诺函议案获通过，10月16日股价下跌1.62%
股市必读：同仁堂新发布《同仁堂 关于控股公司部分药品获得澳门中成药注册证明书的公告》
证券之星 · 10-16
股市必读：同仁堂新发布《同仁堂 关于控股公司部分药品获得澳门中成药注册证明书的公告》
同仁堂（600085）10月14日主力资金净卖出768.45万元
证券之星 · 10-15
同仁堂（600085）10月14日主力资金净卖出768.45万元
同仁堂（600085）披露控股公司部分药品获得澳门中成药注册证明书，10月14日股价上涨1.11%
证券之星 · 10-14
同仁堂（600085）披露控股公司部分药品获得澳门中成药注册证明书，10月14日股价上涨1.11%
同仁堂科技附属公司获澳门6款中成药注册证明书 暂未投入销售
同花顺 · 10-14
同仁堂科技附属公司获澳门6款中成药注册证明书 暂未投入销售
股市必读：同仁堂新发布《同仁堂 关于控股孙公司获得香港中成药注册证明书的公告》
证券之星 · 10-12
股市必读：同仁堂新发布《同仁堂 关于控股孙公司获得香港中成药注册证明书的公告》
同仁堂：控股孙公司获香港定志丸中成药注册证明书
同花顺 · 10-08
同仁堂：控股孙公司获香港定志丸中成药注册证明书
9月30日同仁堂发生1笔大宗交易 成交金额285.83万元
证券之星 · 09-30
9月30日同仁堂发生1笔大宗交易 成交金额285.83万元
同仁堂：以中药工业为核心，推进产业链协同发展
证券之星 · 09-30
同仁堂：以中药工业为核心，推进产业链协同发展
同仁堂：高度重视核心产品的价值挖掘与场景拓展
证券之星 · 09-30
同仁堂：高度重视核心产品的价值挖掘与场景拓展
同仁堂：御药传奇定位高端精品中医药
证券之星 · 09-30
同仁堂：御药传奇定位高端精品中医药
同仁堂：做实内在价值，坚守中医药主业
证券之星 · 09-30
同仁堂：做实内在价值，坚守中医药主业
同仁堂：安宫牛黄丸出货受到阶段性影响
证券之星 · 09-30
同仁堂：安宫牛黄丸出货受到阶段性影响
同仁堂：老字号改革是系统性工程
证券之星 · 09-30
同仁堂：老字号改革是系统性工程
同仁堂：上市公司运用增持、回购等工具需综合研判
证券之星 · 09-30
同仁堂：上市公司运用增持、回购等工具需综合研判
同仁堂：锁阳固精丸在部分区域受到消费者欢迎
证券之星 · 09-30
同仁堂：锁阳固精丸在部分区域受到消费者欢迎
同仁堂：天然牛黄市场价格回落，对公司成本端会带来积极影响
证券之星 · 09-30
同仁堂：天然牛黄市场价格回落，对公司成本端会带来积极影响
同仁堂：员工数量等数据的变化，是受外部市场环境、正常人员交替等多重因素影响
证券之星 · 09-30
同仁堂：员工数量等数据的变化，是受外部市场环境、正常人员交替等多重因素影响
同仁堂：公司账面货币资金需要兼顾日常经营、产能建设、研发投入、渠道布局、风险储备等多方面资金需求
证券之星 · 09-30
同仁堂：公司账面货币资金需要兼顾日常经营、产能建设、研发投入、渠道布局、风险储备等多方面资金需求
加载更多
公司概况
公司名称：
北京同仁堂股份有限公司
所属行业：
医药制造业
上市日期：
1997-06-25
主营业务：
北京同仁堂股份有限公司的主营业务是中成药的生产与销售。公司的主要产品是安宫牛黄丸、同仁牛黄清心丸、同仁大活络丸、六味地黄丸、金匮肾气丸。
发行价格：
7.08
{"stockData":{"symbol":"600085","market":"SH","secType":"STK","nameCN":"同仁堂","latestPrice":24.97,"timestamp":1792479600000,"preClose":25.33,"halted":0,"volume":9709992,"delay":0,"changeRate":-0.0142,"floatShares":1371000000,"shares":1371000000,"eps":0.7074,"marketStatus":"已收盘","change":-0.36,"latestTime":"10-20 15:00:00","open":25.2,"high":25.7,"low":24.88,"amount":245000000,"amplitude":0.0324,"askPrice":24.99,"askSize":167,"bidPrice":24.97,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.7074,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792546200000},"marketStatusCode":5,"adr":0,"adjPreClose":25.33,"symbolType":"stock","openAndCloseTimeList":[[1792459800000,1792467000000],[1792472400000,1792479600000]],"highLimit":27.86,"lowLimit":22.8,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1371470262,"isCdr":false,"pbRate":2.51,"roa":"--","peRate":35.298275,"roe":"5.22%","epsLYR":0.867,"committee":-0.162055,"marketValue":34246000000,"turnoverRate":0.0071,"status":1,"floatMarketCap":34246000000},"requestUrl":"/m/hq/s/600085","defaultTab":"news","newsList":[{"id":"2676789355","title":"股市必读：同仁堂新发布《北京大成律师事务所关于北京同仁堂股份有限公司2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676789355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676789355?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:28","pubTimestamp":1792344491,"startTime":"0","endTime":"0","summary":"公司公告汇总北京大成律师事务所关于北京同仁堂股份有限公司2026年第二次临时股东会的法律意见书北京大成律师事务所就北京同仁堂股份有限公司2026年第二次临时股东会的召集程序、召开程序、出席会议人员资格、表决程序及表决结果等事项出具法律意见书。北京大成律师事务所对本次会议出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0097","BK0196","LU1688375341.USD","BK0028","BK0113","BK0188","BK0183","BK0086","BK0239","600085"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675518302","title":"同仁堂（600085）披露控股股东关于解决和避免同业竞争承诺函议案获通过，10月16日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675518302","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675518302?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:33","pubTimestamp":1792161200,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，同仁堂报收于24.36元，较前一交易日下跌1.62%，最新总市值为334.09亿元。近日，同仁堂发布2026年第二次临时股东会决议公告。公告显示，公司于2026年10月16日召开2026年第二次临时股东会，审议通过《控股股东关于解决和避免与公司同业竞争承诺函的议案》。该议案为普通决议议案，获出席会议股东所持表决权过半数通过；关联股东中国北京同仁堂（集团）有限责任公司回避表决，回避股份719,308,540股；议案对中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600085","BK0097","BK0012","BK0239","BK0196","BK0113","BK0086","BK0183","BK0188","BK0028","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675053433","title":"股市必读：同仁堂新发布《同仁堂 关于控股公司部分药品获得澳门中成药注册证明书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675053433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675053433?lang=zh_cn&edition=full","pubTime":"2026-10-16 01:36","pubTimestamp":1792085770,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，同仁堂报收于24.76元，上涨0.41%，换手率0.73%，成交量9.96万手，成交额2.46亿元。注册持有人为北京同仁堂（澳门）有限公司，相关注册费用合计约50,000元港币，该产品暂未投入澳门销售。此次注册获批暂不会对公司生产经营和业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","600085","BK0239","BK0097","BK0086","BK0012","BK0188","LU1688375341.USD","BK0113","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375645","title":"同仁堂（600085）10月14日主力资金净卖出768.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375645?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:22","pubTimestamp":1792023741,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，同仁堂报收于24.66元，上涨1.11%，换手率0.71%，成交量9.72万手，成交额2.39亿元。10月14日的资金流向数据方面，主力资金净流出768.45万元，占总成交额3.21%，游资资金净流出812.86万元，占总成交额3.4%，散户资金净流入1581.31万元，占总成交额6.61%。近5日资金流向一览见下表：同仁堂融资融券信息显示，融资方面，当日融资买入1872.27万元，融资偿还1510.39万元，融资净买入361.87万元。同仁堂主营业务：中成药的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500006952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0239","BK0196","LU1688375341.USD","BK0086","BK0113","BK0012","600085","BK0097","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675328506","title":"同仁堂（600085）披露控股公司部分药品获得澳门中成药注册证明书，10月14日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675328506","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675328506?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:20","pubTimestamp":1791987627,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，同仁堂报收于24.66元，较前一交易日上涨1.11%，最新总市值为338.2亿元。该股当日开盘24.4元，最高24.78元，最低24.25元，成交额达2.39亿元，换手率为0.71%。注册持有人为北京同仁堂（澳门）有限公司，相关注册费用合计约50,000元港币，该产品暂未投入澳门销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400039890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0113","BK0086","600085","LU1688375341.USD","BK0188","BK0239","BK0097","BK0012","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675310834","title":"同仁堂科技附属公司获澳门6款中成药注册证明书 暂未投入销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2675310834","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675310834?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:20","pubTimestamp":1791969600,"startTime":"0","endTime":"0","summary":"10月14日，北京同仁堂(600085.SH)附属公司北京同仁堂(澳门)有限公司收到澳门中医药管理委员会颁发的《中成药注册证明书》，准许石淋通颗粒、舒肝健胃丸、四神丸、黄精丸、滋补健身丸、状元 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20261014/c680692427.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20261014/c680692427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0113","BK0012","BK0183","BK0086","BK0239","BK0028","BK0188","600085","LU1688375341.USD","BK0097","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184345","title":"股市必读：同仁堂新发布《同仁堂 关于控股孙公司获得香港中成药注册证明书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674184345?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:10","pubTimestamp":1791738622,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股孙公司获香港《中成药注册证明书》，产品“定志丸”获准在港销售，注册编号HKC-18863，有效期至2031年9月29日。公司公告汇总同仁堂 关于控股孙公司获得香港中成药注册证明书的公告北京同仁堂股份有限公司控股孙公司北京同仁堂国药有限公司收到香港中医药管理委员会签发的《中成药注册证明书》，准许“定志丸”在香港出售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0188","BK0183","BK0196","BK0028","BK0012","BK0239","BK0097","BK0086","600085","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020829","title":"同仁堂：控股孙公司获香港定志丸中成药注册证明书","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020829","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673020829?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:53","pubTimestamp":1791449580,"startTime":"0","endTime":"0","summary":"10月8日，同仁堂(600085.SH)公告称，公司控股孙公司北京同仁堂国药有限公司收到香港中医药管理委员会签发的《中成药注册证明书》，准许“定志丸【同仁堂】”在香港出售，注册编号为HKC-1886 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261008/c680482755.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261008/c680482755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0097","600085","LU1688375341.USD","BK0196","BK0188","BK0012","BK0113","BK0028","BK0239","BK0086","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671927055","title":"9月30日同仁堂发生1笔大宗交易 成交金额285.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671927055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671927055?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:33","pubTimestamp":1790760828,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日同仁堂发生大宗交易，交易数据如下：大宗交易成交价格23.74元，成交12.04万股，成交金额285.83万元，买方营业部为广发证券股份有限公司慈溪浒山路证券营业部，卖方营业部为中国国际金融股份有限公司北京建国门外大街证券营业部。近三个月该股共发生1笔大宗交易，合计成交1204.0手。截至2026年9月30日收盘，同仁堂报收于23.74元，上涨1.89%，换手率0.4%，成交量5.5万手，成交额1.3亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000027858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0086","BK0097","LU1688375341.USD","BK0196","BK0028","BK0113","BK0239","600085","BK0183","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671927132","title":"同仁堂：以中药工业为核心，推进产业链协同发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2671927132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671927132?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755063,"startTime":"0","endTime":"0","summary":"同仁堂是否在考虑同样发展路径？未来，若发生重大调整，公司将依法履行信息披露业务。本次股权变更事项完成后，同仁堂集团将统筹推进本公司和嘉事堂的产业协同工作。公司立足自身实际，以中药工业为核心，推进产业链协同发展，持续优化业务结构、聚焦主业提升经营质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0113","BK0012","BK0028","BK0239","BK0183","BK0086","600085","BK0196","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671330271","title":"同仁堂：高度重视核心产品的价值挖掘与场景拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2671330271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671330271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755062,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂(600085)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：建议公司前十大核心产品考虑进行保健预防常服场景的临床研究和推广并产生适合常服的小剂量包装产品，请问公司是否已有上述这方面的安排或计划？同仁堂回复：您好。公司高度重视核心产品的价值挖掘与场景拓展，对于保健预防常服方向的临床研究、学术推广以及核心产品的二次开发，公司会结合现有产品特性、临床循证基础、药监相关法规要求开展可行性评估论证。相关事项如触及披露标准，公司将及时公告。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0239","BK0196","LU1688375341.USD","BK0086","BK0113","BK0012","600085","BK0097","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671713742","title":"同仁堂：御药传奇定位高端精品中医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2671713742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671713742?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755061,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂09月30日在投资者关系平台上答复投资者关心的问题。接下来这两个方向公司打算怎么去做，特别在销售宣传推广方面同仁堂回复：尊敬的投资者，您好！御药传奇定位高端精品中医药，后续将依托线下样板终端、文化 IP 联动，深耕高端及礼赠市场，丰富公司产品矩阵。露酒系列为传统药酒延伸的大健康品类，公司将持续优化产品结构，合规开展品牌宣传。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600085","BK0183","BK0188","BK0097","BK0113","BK0012","BK0196","BK0086","BK0239","LU1688375341.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271532","title":"同仁堂：做实内在价值，坚守中医药主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671271532?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755060,"startTime":"0","endTime":"0","summary":"同仁堂回复：您好，面对当前市场环境，公司的应对策略聚焦于做实内在价值：一是坚守中医药主业，恪守质量为本，持续优化产品结构，推进渠道精细化治理，降本增效，努力改善经营质量；二是持续做好投资者关系管理工作，通过业绩说明会、上证e互动、投资者调研等多种渠道，加强与资本市场沟通，客观传递公司经营现状与发展规划；三是严格执行信息披露，持续完善内控体系，合理实施股东回报相关工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0188","BK0239","BK0196","BK0097","BK0086","BK0012","BK0028","BK0113","LU1688375341.USD","600085"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271328","title":"同仁堂：安宫牛黄丸出货受到阶段性影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671271328?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755059,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂09月30日在投资者关系平台上答复投资者关心的问题。公司坚持以终端需求为导向，适度优化发货节奏，安宫牛黄丸出货受到阶段性影响，但终端实际消费需求仍具备韧性。发货策略主要结合渠道库存、终端动销实况统筹安排，旨在维护产品价格体系，保障品类长期健康发展。。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0183","600085","BK0239","BK0028","BK0113","LU1688375341.USD","BK0012","BK0097","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671227156","title":"同仁堂：老字号改革是系统性工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671227156?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755055,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂(600085)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的改革咋就这么难？就没有一个强有力的改革者吗？这么好的品牌，这么有底蕴的公司，为啥就搞不好呢？同仁堂回复：感谢您的关切与对公司品牌的认可。老字号改革是系统性工程，受历史基础、治理机制、市场环境等多重现实条件约束，需要统筹兼顾、稳步推进。公司会认真吸纳市场各类合理化建议，苦练内功，力争将品牌底蕴转化为经营实绩。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1688375341.USD","BK0097","BK0188","BK0113","600085","BK0012","BK0183","BK0196","BK0239","BK0086","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671727155","title":"同仁堂：上市公司运用增持、回购等工具需综合研判","url":"https://stock-news.laohu8.com/highlight/detail?id=2671727155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671727155?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755052,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂09月30日在投资者关系平台上答复投资者关心的问题。咱们同仁堂的股价跌了三年，股价腰斩再腰斩，咱们的大股东竟一动不动，就不能向人家学习一下回购股份维护股价吗？二级市场股价受宏观环境、行业、市场情绪、公司基本面等多重因素影响。上市公司运用增持、回购等工具，需结合自身资金情况、发展战略以及国资监管审批相关要求等综合因素开展综合研判，审慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600085","BK0196","BK0239","BK0012","BK0188","BK0028","BK0086","BK0183","BK0097","BK0113","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671027135","title":"同仁堂：锁阳固精丸在部分区域受到消费者欢迎","url":"https://stock-news.laohu8.com/highlight/detail?id=2671027135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671027135?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755050,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂09月30日在投资者关系平台上答复投资者关心的问题。公司许昌天使城门店的锁阳固精丸卖爆了，排队购买的人络绎不绝，这是除了安宫牛黄丸之后的又一爆品，为什么销售量如此火爆确没有反应在股价上呢？您提到的，锁阳固精丸在部分区域受到消费者欢迎，也代表市场对公司产品力的认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0113","BK0012","BK0028","BK0239","BK0183","BK0086","600085","BK0196","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671633271","title":"同仁堂：天然牛黄市场价格回落，对公司成本端会带来积极影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2671633271","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671633271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755044,"startTime":"0","endTime":"0","summary":"随着原有库存的消耗和市场动销的逐步改善，牛黄核心原料的生产成本将逐步回归。同时为确保稳定生产，公司对牛黄进行合理的战略储备，低价位牛黄原料的采购入库会对成本端有一定的平滑作用。公司积极布局进口牛黄，构建多元原料保障体系，进口牛黄采购价格受产地、品质、市场行情等因素影响，采购均遵循市场化原则。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1688375341.USD","BK0028","BK0196","BK0113","BK0239","BK0183","BK0188","BK0086","BK0097","600085"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271593","title":"同仁堂：员工数量等数据的变化，是受外部市场环境、正常人员交替等多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671271593?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755042,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂09月30日在投资者关系平台上答复投资者关心的问题。员工数量等数据的变化，是受外部市场环境、正常人员交替等多重因素影响。目前公司各项业务运营正常，员工队伍稳定。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600085","BK0113","BK0196","BK0183","LU1688375341.USD","BK0188","BK0028","BK0012","BK0097","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671632271","title":"同仁堂：公司账面货币资金需要兼顾日常经营、产能建设、研发投入、渠道布局、风险储备等多方面资金需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2671632271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671632271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:57","pubTimestamp":1790755036,"startTime":"0","endTime":"0","summary":"证券之星消息，同仁堂(600085)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：公司现金储备100亿，为什么不提高分红比例？同仁堂回复：您好。公司账面货币资金需要兼顾日常经营、产能建设、研发投入、渠道布局、风险储备等多方面资金需求。公司利润分配方案结合年度盈利状况、未来经营资金需求、公司章程及相关规定综合制定，兼顾股东当期收益与企业长远发展。公司的分红方案，还请您关注公司公告。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000022194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0086","BK0188","BK0097","BK0183","600085","BK0196","LU1688375341.USD","BK0012","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792486290511,"stockEarnings":[{"period":"1week","weight":0.0368},{"period":"1month","weight":0.0909},{"period":"3month","weight":-0.022},{"period":"6month","weight":-0.0627},{"period":"1year","weight":-0.2445},{"period":"ytd","weight":-0.1975}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0463},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0914},{"period":"1year","weight":-0.0283},{"period":"ytd","weight":-0.0599}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京同仁堂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"137818人(较上一季度减少2.15%)","perCapita":"9951股","listingDate":"1997-06-25","address":"北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街33号","registeredCapital":"137147万元","survey":" 北京同仁堂股份有限公司的主营业务是中成药的生产与销售。公司的主要产品是安宫牛黄丸、同仁牛黄清心丸、同仁大活络丸、六味地黄丸、金匮肾气丸。","listedPrice":7.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同仁堂(600085)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同仁堂(600085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同仁堂,600085,同仁堂股票,同仁堂股票老虎,同仁堂股票老虎国际,同仁堂行情,同仁堂股票行情,同仁堂股价,同仁堂股市,同仁堂股票价格,同仁堂股票交易,同仁堂股票购买,同仁堂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同仁堂(600085)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同仁堂(600085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}